RxDoctor Payments Data

Ronald Sulewski, MD

Dermatology · Omaha, NENPI 1063684348

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 159 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,555 and has fallen 92.5% since, to $192 in 2025.

$3,159in general payments, 2019–2025

Across 159 payments — averaging $19.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$660
  • Dermira, Inc.$346
  • Novartis$273
  • Pfizer$194
  • Sun Pharmaceutical Industries Inc.$158
  • UCB, Inc.$154
  • plus $1K from 24 others

What the payments were for

  • Food & beverage$3,159100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,159 in reported general payments places this provider in the 60th percentile of 68 dermatology providers in Nebraska.

See all dermatology providers in Nebraska

Medicare billing

Part B allowed, 2024
$53,704
Medicare patients
323
Services billed
1,366

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate18$1,188
Ketoconazole60$972
Triamcinolone Acetonide61$528
Hydroxyzine Hcl26$294
Doxepin Hcl13$166
Hydrocortisone20$117
Levocetirizine Dihydrochloride13$93
ValacyclovirValacyclovir Hcl11$37

Paid to pharmacies, not to this prescriber.

Other dermatology in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →